RE: Assay Results RNS18 Nov 2025 10:04
Additionally - as we are all investors with Wishbone - when it comes to the assay results (or waiting for the results) - the questions we should be asking Wishbone (or Wishbone should be telling us is)…..
Given that ALS is the lab….
1. Which ALS Lab / Location
• Which ALS facility are they using (country / lab name)?Since different ALS labs may have different workloads.
2. Assay Methods
• What exact assay method are they using (fire assay, ICP, photon assay, screen metallic, etc.)?
• Are any over-limit re-assays anticipated?
3. Expected Turnaround (from Wishbone)
• When they submitted the samples, what TAT did they expect (based on their “service order”)?
• Can they provide a breakdown (prep time, analysis time, QA time)?
4. QA/QC Protocols
• What QA/QC did they run (standards, blanks, duplicates)?
• Have any re-assays been requested by the company because of QA issues?
5. Partial Result Strategy
• Will they publish partial assay batches (e.g., first 4 holes) while waiting for the rest?
• When do they expect to make a public release?
6. Historical Lab Performance
• Have they used ALS before on this project (or other projects)? If yes, what were their past TATs?